Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
IL 15 enhances preclinical efficacy of anti-core 1 O-glycans monoclonal antibody NEO-201 against human endometrial and ovarian cancer.
Journal: Frontiers in immunology
Published: June 23, 2025
Correction: First-in-human phase 1 clinical trial of anti-core 1 O-glycans targeting monoclonal antibody NEO-201 in treatment-refractory solid tumors.
Journal: Journal of experimental & clinical cancer research : CR
Published: April 26, 2023
Correction: Intraperitoneal Monocytes plus IFNs as a Novel Cellular Immunotherapy for Ovarian Cancer: Mechanistic Characterization and Results from a Phase I Clinical Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 17, 2023
First-in-human phase 1 clinical trial of anti-core 1 O-glycans targeting monoclonal antibody NEO-201 in treatment-refractory solid tumors.
Journal: Journal of experimental & clinical cancer research : CR
Published: January 09, 2023
SMAC Mimetics Synergistically Cooperate with HDAC Inhibitors Enhancing TNF-α Autocrine Signaling.
Journal: Cancers
Published: December 22, 2022
Intraperitoneal Monocytes plus IFNs as a Novel Cellular Immunotherapy for Ovarian Cancer: Mechanistic Characterization and Results from a Phase I Clinical Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 14, 2022
Driving Immune Responses in the Ovarian Tumor Microenvironment.
Journal: Frontiers in oncology
Published: September 08, 2020
Showing 1-7 of 7
Last Updated: 09/26/2026